Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 675

1.

A clinician's guide to biosimilars in oncology.

Rugo HS, Linton KM, Cervi P, Rosenberg JA, Jacobs I.

Cancer Treat Rev. 2016 Apr 21;46:73-79. doi: 10.1016/j.ctrv.2016.04.003. [Epub ahead of print] Review.

PMID:
27135548
2.

International Pediatric Otolaryngology Group (IPOG) consensus recommendations: Routine peri-operative pediatric tracheotomy care.

Strychowsky JE, Albert D, Chan K, Cheng A, Daniel SJ, De Alarcon A, Garabedian N, Hart C, Hartnick C, Inglis A, Jacobs I, Kleinman ME, Mehta NM, Nicollas R, Nuss R, Pransky S, Russell J, Rutter M, Schilder A, Thompson D, Triglia JM, Volk M, Ward B, Watters K, Wyatt M, Zalzal G, Zur K, Rahbar R.

Int J Pediatr Otorhinolaryngol. 2016 Apr 4. pii: S0165-5876(16)30022-2. doi: 10.1016/j.ijporl.2016.03.029. [Epub ahead of print]

PMID:
27132195
3.

New therapy, new challenges: The effects of long-term continuous flow left ventricular assist device on inflammation.

Grosman-Rimon L, Billia F, Fuks A, Jacobs I, A McDonald M, Cherney DZ, Rao V.

Int J Cardiol. 2016 Apr 19;215:424-430. doi: 10.1016/j.ijcard.2016.04.133. [Epub ahead of print] Review.

PMID:
27131263
4.

International Pediatric ORL Group (IPOG) laryngomalacia consensus recommendations.

Carter J, Rahbar R, Brigger M, Chan K, Cheng A, Daniel SJ, De Alarcon A, Garabedian N, Hart C, Hartnick C, Jacobs I, Liming B, Nicollas R, Pransky S, Richter G, Russell J, Rutter MJ, Schilder A, Smith RJ, Strychowsky J, Ward R, Watters K, Wyatt M, Zalzal G, Zur K, Thompson D.

Int J Pediatr Otorhinolaryngol. 2016 Apr 7. pii: S0165-5876(16)30051-9. doi: 10.1016/j.ijporl.2016.04.007. [Epub ahead of print] Review.

PMID:
27107728
5.

Assessing the Immunogenicity of Biopharmaceuticals.

Pineda C, Castañeda Hernández G, Jacobs IA, Alvarez DF, Carini C.

BioDrugs. 2016 Apr 20. [Epub ahead of print] Review.

PMID:
27097915
6.

Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).

Fourkala EO, Blyuss O, Field H, Gunu R, Ryan A, Barth J, Jacobs I, Zaikin A, Dawnay A, Menon U.

Steroids. 2016 Jun;110:62-9. doi: 10.1016/j.steroids.2016.04.003. Epub 2016 Apr 16.

PMID:
27091764
7.

Mindfulness facets, trait emotional intelligence, emotional distress, and multiple health behaviors: A serial two-mediator model.

Jacobs I, Wollny A, Sim CW, Horsch A.

Scand J Psychol. 2016 Jun;57(3):207-14. doi: 10.1111/sjop.12285. Epub 2016 Apr 8.

PMID:
27062306
8.

Evaluating imbalances of adverse events during biosimilar development.

Vana AM, Freyman AW, Reich SD, Yin D, Li R, Anderson S, Jacobs IA, Zacharchuk CM, Ewesuedo R.

MAbs. 2016 Apr 6:0. [Epub ahead of print]

PMID:
27050730
9.

Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations.

Manchanda R, Burnell M, Loggenberg K, Desai R, Wardle J, Sanderson SC, Gessler S, Side L, Balogun N, Kumar A, Dorkins H, Wallis Y, Chapman C, Tomlinson I, Taylor R, Jacobs C, Legood R, Raikou M, McGuire A, Beller U, Menon U, Jacobs I.

J Med Genet. 2016 Mar 18. pii: jmedgenet-2015-103740. doi: 10.1136/jmedgenet-2015-103740. [Epub ahead of print]

PMID:
26993268
10.

Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology.

Mysler E, Pineda C, Horiuchi T, Singh E, Mahgoub E, Coindreau J, Jacobs I.

Rheumatol Int. 2016 May;36(5):613-25. doi: 10.1007/s00296-016-3444-0. Epub 2016 Feb 27. Review.

PMID:
26920148
11.

Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma.

Coleman M, Lammers PE, Ciceri F, Jacobs IA.

Clin Lymphoma Myeloma Leuk. 2016 Apr;16(4):175-81. doi: 10.1016/j.clml.2016.01.004. Epub 2016 Jan 30. Review.

PMID:
26906106
12.

Biosimilars and cancer treatment of older patients.

Lichtman SM, Reske T, Jacobs IA.

J Geriatr Oncol. 2016 Mar;7(1 Suppl):S1-8. doi: 10.1016/j.jgo.2016.01.002. Epub 2016 Feb 5.

13.

Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications.

Younger A, Rac G, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, Maclachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner E.

Urology. 2016 May;91:46-51. doi: 10.1016/j.urology.2015.12.057. Epub 2016 Feb 1.

PMID:
26845051
14.

Serial Patterns of Ovarian Cancer Biomarkers in a Prediagnosis Longitudinal Dataset.

Blyuss O, Gentry-Maharaj A, Fourkala EO, Ryan A, Zaikin A, Menon U, Jacobs I, Timms JF.

Biomed Res Int. 2015;2015:681416. doi: 10.1155/2015/681416. Epub 2015 Dec 24.

15.

Protein Z: A putative novel biomarker for early detection of ovarian cancer.

Russell MR, Walker MJ, Williamson AJ, Gentry-Maharaj A, Ryan A, Kalsi J, Skates S, D'Amato A, Dive C, Pernemalm M, Humphryes PC, Fourkala EO, Whetton AD, Menon U, Jacobs I, Graham RL.

Int J Cancer. 2016 Jun 15;138(12):2984-92. doi: 10.1002/ijc.30020. Epub 2016 Feb 19.

PMID:
26815306
16.

Statistical Primer on Biosimilar Clinical Development.

Isakov L, Jin B, Jacobs IA.

Am J Ther. 2016 Jan 13. [Epub ahead of print]

PMID:
26766293
17.

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial.

Santagostino E, Martinowitz U, Lissitchkov T, Pan-Petesch B, Hanabusa H, Oldenburg J, Boggio L, Negrier C, Pabinger I, von Depka Prondzinski M, Altisent C, Castaman G, Yamamoto K, Álvarez-Roman MT, Voigt C, Blackman N, Jacobs I; PROLONG-9FP Investigators Study Group.

Blood. 2016 Apr 7;127(14):1761-9. doi: 10.1182/blood-2015-09-669234. Epub 2016 Jan 11.

18.

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E, Cruickshank D, Crump DN, Davies SK, Dawnay A, Dobbs S, Fletcher G, Ford J, Godfrey K, Gunu R, Habib M, Hallett R, Herod J, Jenkins H, Karpinskyj C, Leeson S, Lewis SJ, Liston WR, Lopes A, Mould T, Murdoch J, Oram D, Rabideau DJ, Reynolds K, Scott I, Seif MW, Sharma A, Singh N, Taylor J, Warburton F, Widschwendter M, Williamson K, Woolas R, Fallowfield L, McGuire AJ, Campbell S, Parmar M, Skates SJ.

Lancet. 2016 Mar 5;387(10022):945-56. doi: 10.1016/S0140-6736(15)01224-6. Epub 2015 Dec 17. Erratum in: Lancet. 2016 Mar 5;387(10022):944.

19.

Measurement of Small Molecular Dopant F4TCNQ and C60F36 Diffusion in Organic Bilayer Architectures.

Li J, Rochester CW, Jacobs IE, Friedrich S, Stroeve P, Riede M, Moulé AJ.

ACS Appl Mater Interfaces. 2015 Dec 30;7(51):28420-8. doi: 10.1021/acsami.5b09216. Epub 2015 Dec 16.

PMID:
26673846
20.

Genetic screening for gynecological cancer: where are we heading?

Manchanda R, Jacobs I.

Future Oncol. 2016 Jan;12(2):207-20. doi: 10.2217/fon.15.278. Epub 2015 Dec 7.

PMID:
26638726
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk